The role of inhaled antibiotics in bronchial infection Source: Eur Respir Monogr 2013; 60: 120-126 Year: 2013
Viral, bacterial or both? Regardless, we need to treat infection in COPD Source: Eur Respir J 2014; 44: 11-13 Year: 2014
Frequency and pecularities of flow pulmonary tuberculosis (PT) in patients with different forms of diabetes mellitus (DM) in up-to-date conditions Source: Eur Respir J 2002; 20: Suppl. 38, 363s Year: 2002
From cell cultures to autopsies: study on functionality across different experimental models in SARS-CoV-2 infection. Source: Virtual Congress 2021 – Back to infection basics Year: 2021
Microbiological approaches to respiratory infections: where now, and where next? Source: Annual Congress 2005 - PG5 - Paediatrics: respiratory infections in children Year: 2005
Role of haptogobins genetically determined phenotypes in the development, treatment and prevention pulmonary tuberculosis Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010
Modelling acute lung injury: infections versus bacterial components Source: Annual Congress 2012 - PG4 Experimental models for respiratory medicine: strengths and limitations Year: 2012
Early re-colonization with pseudomonas aeruginosa (PA) after treatment: a possible risk factor for development of chronic infection in cystic fibrosis (CF) patients Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008
Efficacy evaluation, time estimates for method of bronchial valve closure (BVC) in the treatment of patients with double infections of immunodeficiency virus / tuberculosis (HI virus/TB) Source: International Congress 2019 – Interventional pulmonology: current pleural practice Year: 2019
Pulmonary tuberculosis (TB) in the adult: comparative analysis of two different groups Source: Eur Respir J 2002; 20: Suppl. 38, 362s Year: 2002
Intrapulmonary penetration of antimicrobials and implications in the treatment of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=13 Year: 2004
Do results of T-SPOT.TB assays change during and after treatment of active tuberculosis? Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection Year: 2006
Microarray analysis of pulmonary gene expression in mice lacking the vasoactive intestinal peptide (VIP) gene: confirmation of a role in asthma and pulmonary arterial hypertension (PAH) Source: Annual Congress 2006 - Cellular mechanisms of airway disease Year: 2006
Screening for hickman line related infection in patients with severe pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 582s Year: 2003
SERCA2a gene therapy ameliorates pulmonary hypertension in a pig model: comparison of different delivery methods and therapeutic effect Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020
Studying lung inflammatory biomarkers using non-invasive methods in patients with community acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002
Comparative evaluation of different methods of correction of mucociliary transport (MCT) insufficiency in patients with chronic bronchitis (CB) Source: Annual Congress 2006 - Implications of progressive airway obstruction Year: 2006
The use of phon resonant therapy (PRT) in treatment of patients with pulmonary tuberculosis, combined with infections, caused by chlamydia (C) and mycoplasma (M) Source: Eur Respir J 2004; 24: Suppl. 48, 52s Year: 2004
Over expression of endothelin-1 (ET-1) in lung fibroblasts (LFb) from patients with pulmonary arterial hypertension (PAH), evidence for loss of inhibitory control Source: International Congress 2016 – New findings in mucosal immunology Year: 2016
High « red cell distribution width » levels can predict pulmonary embolism risk in multiple trauma patients: a case control study. Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism Year: 2018